1. Home
  2. BHC

as of 01-27-2026 3:44pm EST

$5.77
$0.00
-0.09%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Founded: N/A Country:
Canada
Canada
Employees: N/A City: QUEBEC
Market Cap: 2.5B IPO Year: N/A
Target Price: $8.50 AVG Volume (30 days): 2.1M
Analyst Decision: Hold Number of Analysts: 4
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.97 EPS Growth: N/A
52 Week Low/High: $4.25 - $8.69 Next Earning Date: 02-18-2026
Revenue: $10,029,000,000 Revenue Growth: 5.86%
Revenue Growth (this year): 6.81% Revenue Growth (next year): 4.11%

AI-Powered BHC Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 77.36%
77.36%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: